LeRoux is a seasoned biotech executive with recent experience in regenerative medicine and developing stem cell-based treatments for macular degeneration at Ocata Therapeutics (acquired by Astellas Pharma in 2016).
LeRoux has prior experience in big pharma (Eli Lilly, Wyeth, Cephalon) and startup biotech (Aton Pharma, Antares, and Akili Interactive).
This person is not in any teams
This person is not in any offices